• J Emerg Med · Mar 2022

    Randomized Controlled Trial

    A Randomized, Placebo-Controlled Study of Intranasal Fentanyl as an Analgesic Adjunct For Incision and Drainage of Abscess.

    • Alex Latev, Jesse Baer, Shellyann Sharpe, Chiraag Gupta, Carmen Feliciano, and Benjamin W Friedman.
    • Department of Emergency Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
    • J Emerg Med. 2022 Mar 1; 62 (3): 291-297.

    BackgroundIncision and drainage (I&D) of abscesses is one of the most painful procedures performed in emergency departments (EDs).ObjectiveWe tested the following hypothesis: The addition of intranasal fentanyl to the standard practice of local infiltration with lidocaine would provide better pain control than lidocaine alone for adult ED patients undergoing I&D.MethodsThis was a randomized, double-blind study. Participants received 2 μg/kg of intranasal fentanyl or a comparable amount of intranasal water in addition to local lidocaine infiltration. The primary outcome, which we assessed immediately after the I&D was completed, was a summary 0-10 pain score for which we asked study subjects to provide a number depicting their entire experience with the procedure.ResultsDuring a 19-month enrollment period, we screened 176 patients for eligibility and enrolled 49; 25 received placebo and 24 received fentanyl. Baseline characteristics were comparable. Mean (standard deviation) summary pain scores were as follows: fentanyl 6.2 (3.3) and placebo 7.0 (3.2). The 95% confidence interval for a rounded between-group difference of 0.9 was -1.1 to 2.6.ConclusionsIn this small study, the addition of intranasal fentanyl did not substantially impact the pain scores of ED patients undergoing I&D.Copyright © 2021. Published by Elsevier Inc.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…